The Blog

Improving Diversity, Equity and Inclusion in Clinical Trials

Enhancing diversity, equity and inclusion (DEI) in clinical trial populations is a moral imperative. It has long been acknowledged that DEI is crucial for broadening the scope, creativity and innovativeness of medical research and bolsters success in solving complex problems whilst reducing inequities in health and disease.

InkLab Medical Communications

Effective continuing medical education (CME) programmes raise standards and enable HCPs to improve knowledge and skills through lifelong learning.

Medical Writing Checklist

Medical Writing Checklist We, at Inklab Communications, have put together a helpful checklist for medical writers to use in order to hone and add value to a prospective powerpoint slide deck.

Social media and the anti-vaccine movement

Vaccinations are estimated to save 2–3 million lives each year; however, with misinformation and ‘fake news’ so easily spread across social media platforms, the anti-vaccine movement has gathered momentum and threatens to undo substantial progress made against multiple preventable diseases.

The future of effective HCP communication

Compliant, obedient, and unknowledgeable. That’s how the patient landscape used to look to HCPs. Patients were wholly reliant on HCPs to provide them with the correct diagnosis and the most appropriate medication.

PR plan for pharma

The price of researching and developing new medicines is very high and so ensuring that a new drug is adopted is of paramount importance to pharma companies. Having a strategic Public Relations (PR) plan will help…

Why no-deal Brexit means fake pharma

Medicines are the most common medical intervention used across the UK and Europe. Unfortunately, falsified or fake medicines are entering global supply chains and have become a leading public health concern worldwide.

Brexit and the pharma industry

Brexit is only a stone’s throw away yet there are increasing concerns regarding the effect it will have on the pharmaceutical industry and the supply of medicines to patients.

Key opinion leaders

KOLs have an influential quality coveted by pharmaceutical companies. In this blog, we look at the role of KOLs and how to create an effective partnership with them.